Brooks Nader Opens Up About GLP-1 Weight Loss Drug and Its Impact on Her Career

Brooks Nader, a 28-year-old model, recently shared her experiences with a GLP-1 weight loss drug in an interview.

She revealed that her use of the medication has significantly contributed to her career success, although she acknowledges that her family has concerns about her dependency on it.

In her candid conversation with Bustle, Nader admitted that she feels “addicted” to the drug, even though she recognizes the need to stop using it.

The Impact on Her Career

Nader explained that her career took off after she began using GLP-1.

She stated, “When I started GLP-1, my career took off.”

While she is not endorsing the drug as a healthy choice, she noted that it helped her lose 30 pounds and secure numerous modeling jobs.

Her breakthrough came in 2019 when she was featured in Sports Illustrated, and by 2023, she had become a cover star.

Brooks Nader revealed in a new interview that using a GLP-1 weight loss drug has contributed to her successful career; pictured November 4

Navigating Industry Pressure

In the interview, Nader discussed how she handles rejection in the competitive modeling industry.

If she did not get a job, she would reach out to her former agency for feedback from the clients.

She recalled being told that she needed to lose weight, stating, “The facts are they want me to lose weight. How can I achieve that?”

Nader’s straightforward approach to feedback illustrates her determination to succeed in a challenging field.

Family Concerns

Brooks Nader previously addressed her use of the GLP-1 drug after her sisters teased her about it on TikTok.

In a past interview, she admitted, “I tried it out when it first came out, and I liked it, I can’t lie.”

However, her family has expressed worries about her health due to her reliance on the medication.

During an episode of her family’s reality show, Love Thy Nader, her sister Mary Holland voiced her concerns after Brooks mentioned experiencing adverse effects during an exercise class.

Mary commented, “Just seeing all of the needles piled up in one place makes me realize the gravity of how deep she’s gone in it.”

Brooks' modeling trajectory ascended when she was cast to appear inside the pages of Sports Illustrated in 2019. By 2023 she had become a cover star

Struggling with Body Image

Brooks has been open about her struggles with body image and the pressure she feels as a model.

In the series, she discussed her use of GLP-1s and the impact it has had on her physical and mental well-being.

She admitted to micro-dosing the drug but increased her dosage in preparation for a modeling gig, wanting to look her best.

This admission highlights the lengths to which some models go to conform to industry standards.

Acknowledging the Stigma

Nader expressed surprise at the number of people who reached out to her after she opened up about her use of GLP-1.

Many shared their own experiences with the drug and the stigma surrounding it.

She stated, “I’m still on it. It’s a crutch for me, too. It’s not healthy. I should get off it; I’ll be honest about that.”

This acknowledgment of her dependency reveals a deeper understanding of the challenges faced by those in the modeling industry.

Cosmetic Procedures and Health

In addition to her use of GLP-1, Brooks has undergone various cosmetic procedures, including veneers, a nose job, and Botox treatments.

She has been candid about her desire to maintain her appearance in a competitive field.

Before her interview with Bustle, Nader took a break from the medication while competing on Dancing With the Stars in 2024.

She found the physical demands of the show taxing and decided to pause her use of the drug during that time.

She plainly stated, 'The facts are that when I started GLP-1, my career took off. I¿m not saying it¿s OK. I¿m not saying it¿s right. I think everybody is different - but I lost 30 pounds, and I booked all the jobs,'; pictured in June 2024

Future Considerations

Despite her break from the medication, Nader has not ruled out returning to it in the future.

She stated, “I mean, never say never… as of right now, no.”

Nader emphasized her commitment to staying healthy and working out, hoping that she will not need to rely on GLP-1 again.

Her journey reflects the ongoing struggle many face in balancing health, career aspirations, and societal expectations.

Conclusion

Brooks Nader’s candid discussion about her use of GLP-1 weight loss drugs sheds light on the pressures faced by models in the fashion industry.

While she credits the medication with helping her career, she is also aware of the potential health risks associated with its use.

Her story resonates with many who grapple with body image and the desire to succeed in competitive environments.

As she navigates her career and personal health, Nader’s experiences highlight the complexities of maintaining a public persona while striving for authenticity in a world filled with expectations.

The conversation around GLP-1 and its implications continues, reminding us of the importance of open dialogue about health and body image in the modeling industry.

Brooks Nader’s journey is a reflection of the challenges many face, and her willingness to share her story may encourage others to speak out about their own experiences.